QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,830 signal articles · 527 in last 24h · 105,883 total before filter · latest 27m ago
527last 24h
2478last 7d
487● bullish (7d)
253● bearish (7d)
200publishers
AllMacro164Earnings1538M&A144Regulatory14Product8Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
DA Davidson Boosts Oracle (ORCL) Price Target Following Q4 Report
Insider Monkey51d agoneutral
DA Davidson Boosts Oracle (ORCL) Price Target Following Q4 Report

Oracle Corporation (NYSE:ORCL) is included among the 14 Best S&P 500 Stocks to Buy Now According to Analysts. Oracle Corporation (NYSE:ORCL) is a global leader in AI, delivering the cloud infrastructure, data, and applications that organizations across the world trust to successfully achieve business outcomes at scale. On June 11, DA Davidson boosted its price […]

Barlcays Lifts KLA (KLAC) Price Target by $500. Here is Why
Insider Monkey51d agoneutral
Barlcays Lifts KLA (KLAC) Price Target by $500. Here is Why

KLA Corporation (NASDAQ:KLAC) is included among the 14 Best S&P 500 Stocks to Buy Now According to Analysts. KLA Corporation (NASDAQ:KLAC) develops industry-leading equipment and services that enable innovation throughout the electronics industry. The company provides advanced process control and process-enabling solutions for manufacturing wafers and reticles, integrated circuits, packaging, and printed circuit boards. On […]

How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum
Simply Wall St.51d agobullish
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum

West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...

Another analyst raises Robinhood price target
TheStreet52d agoneutral
Another analyst raises Robinhood price target

Founded by Stanford graduates Vladimir Tenev and Baiju Bhatt in 2013, Robinhood Markets (Nasdaq: HOOD) is a brokerage platform that has become popular with its stock, cryptocurrency, and tokenized stock offerings. The company's stock hit the all-time high (ATH) of $153.86 on ...

Investing.com52d agobullish
Paychex upgraded to Buy by Citi on growth rebound, AI tailwinds

Investing.com -- Paychex received an upgrade from Citi, which raised its rating on the human capital management company to Buy from Neutral and increased its price target to $140 from $99, citing improving growth trends, benefits from the Paycor acquisition, and emerging AI-driven opportunities.

Investing.com52d agobearish
Accenture downgraded by Morgan Stanley as AI spending crowds out IT service demand

Investing.com -- Morgan Stanley downgraded Accenture to Equal-weight from Overweight and slashed its price target to $177 from $240, arguing that the anticipated boost to IT services spending from artificial intelligence investments has yet to materialize as enterprises continue to prioritize AI projects over traditional discretionary technology spending.

SpaceX Raised $85.7 Billion After Underwriter ‘Green-Shoe Option’
The Wall Street Journal52d agoneutral
SpaceX Raised $85.7 Billion After Underwriter ‘Green-Shoe Option’

SpaceX raised $85.7 billion in its IPO, the company said in a press release Monday. That’s up from the $75 billion that SpaceX initially sold in its public offering on Friday. The additional proceeds come from underwriters exercising their so-called “green-shoe option,” an overallotment of 83.

Verizon Upgraded, Oracle Downgraded: Updated Rankings on Top Blue-Chip Stocks
InvestorPlace52d agoneutral
Verizon Upgraded, Oracle Downgraded: Updated Rankings on Top Blue-Chip Stocks

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 99 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Upg

Rocket Lab and Firefly Get Upgrades. Why the Space Selloff Was ‘Unwarranted.’
Barrons.com52d agoneutral
Rocket Lab and Firefly Get Upgrades. Why the Space Selloff Was ‘Unwarranted.’

Shares of Rocket Lab and Firefly Aerospace advanced before the opening bell on Monday after the space stocks received upgrades following the sharp sector selloff late last week on Elon Musk’s SpaceX initial public offering debut. KeyBanc Capital Markets analysts Michael Leshok and Liam Baker on Sunday upgraded both Rocket Lab and Firefly to Overweight from their previous Sector Weight, setting price targets of $135 and $50, respectively for the space stocks. “Last Friday’s record-setting SpaceX IPO sent ripple effects across our coverage of space-centric equities, with the sector selling off sharply on IPO day and over the weeks leading up to it,” Leshok and Baker wrote.

Investing.com52d agobullish
These 2 space stocks were upgraded at KeyBanc today

Investing.com -- KeyBanc Capital Markets upgraded two space stocks to Overweight from Sector Weight in a note on Monday, arguing that recent sector-wide volatility tied to SpaceX's record-setting IPO has created compelling entry points across commercial space names.

Ferrari Shares Rally After Morgan Stanley Upgrade on Valuation Opportunity
InvestorsHub52d agobullish
Ferrari Shares Rally After Morgan Stanley Upgrade on Valuation Opportunity

Morgan Stanley upgraded Ferrari (NYSE:RACE) to Overweight from Equal Weight on Monday, arguing that the luxury carmaker’s recent share price weakness has become disconnected from the underlying fundamentals of the business. The investment bank also increased its price target to €380 from €330, suggesting potential upside of around 24% from Friday’s closing level.

Stifel Raises Price Target for Cadence Design (CDNS) Following Intel Foundry Partnership
Insider Monkey52d agobullish
Stifel Raises Price Target for Cadence Design (CDNS) Following Intel Foundry Partnership

Cadence Design Systems Inc. (NASDAQ:CDNS) ranks among the best 5G stocks to buy right now. On June 9, Stifel maintained its Buy rating on Cadence Design Systems Inc. (NASDAQ:CDNS) and increased its price target from $395 to $432, citing Cadence’s announcement of a multi-year Design Technology Co-Optimization partnership with Intel Foundry aimed at Intel 14A. […]

Citi Calls AMD a Rising Force in the GPU Market, Upgrades Shares to Buy
Insider Monkey52d agobullish
Citi Calls AMD a Rising Force in the GPU Market, Upgrades Shares to Buy

Advanced Micro Devices, Inc. (NASDAQ:AMD) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 12, Citi upgraded Advanced Micro Devices, Inc. (NASDAQ:AMD) to Buy from Neutral. It also raised the firm’s price target to $575 from $460. The firm believes the upside from AMD’s graphics processing unit business is not fully reflected […]

Applied Materials (AMAT) Gets Higher Price Targets from Barclays and Cantor Fitzgerald
Insider Monkey52d agoneutral
Applied Materials (AMAT) Gets Higher Price Targets from Barclays and Cantor Fitzgerald

Applied Materials, Inc. (NASDAQ:AMAT) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 11, Barclays raised the firm’s price recommendation on Applied Materials, Inc. (NASDAQ:AMAT) to $590 from $500. It reiterated an Overweight rating on the shares. Analyst Tom O’Malley increased his estimates for wafer fab equipment spending, saying the capital expenditure […]

Citi Sticks with Buy on Baker Hughes (BKR) Despite Lowering Price Target
Insider Monkey52d agobullish
Citi Sticks with Buy on Baker Hughes (BKR) Despite Lowering Price Target

Baker Hughes Company (NASDAQ:BKR) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 3, Citi lowered its price recommendation on Baker Hughes Company (NASDAQ:BKR) to $74 from $80. It reiterated a Buy rating on the stock. The revision came as the firm updated its models for companies in the oil and gas […]

Cava Group (CAVA) Stock Valuation After UBS Upgrade And Expanded Growth Targets
Simply Wall St.52d agobullish
Cava Group (CAVA) Stock Valuation After UBS Upgrade And Expanded Growth Targets

Why CAVA Group (CAVA) is back in focus UBS recently upgraded CAVA Group (CAVA), highlighting strong same store sales and an ambitious unit growth plan, just as the company lifted its 2026 restaurant opening targets and outlined a sizeable workforce expansion. See our latest analysis for CAVA Group. CAVA’s recent analyst upgrade and expansion push have coincided with strong momentum, with a 7 day share price return of 25.33% and a year to date share price return of 50.27%, while the 3 year...

Oppenheimer issues bold price target on SpaceX stock
TheStreet53d agoneutral
Oppenheimer issues bold price target on SpaceX stock

SpaceX’s (SPCX) historic IPO kicked off with a valuation few companies ever touch. Consequently, it also left investors wondering how much upside is left, or whether profit-taking is about to begin. SpaceX's stock, priced at $135, raised $75 billion, opening a brand new chapter for Elon Musk’s ...

Why Cheesecake Factory (CAKE) Is Up 13.8% After Q1 Beat And JPMorgan Upgrade - And What's Next
Simply Wall St.53d agobullish
Why Cheesecake Factory (CAKE) Is Up 13.8% After Q1 Beat And JPMorgan Upgrade - And What's Next

Earlier this week, The Cheesecake Factory reported strong first-quarter 2026 results, including a 1.6% increase in same-store sales and earnings that exceeded analyst expectations, followed by a ratings upgrade from JPMorgan. This combination of improving operational performance and a more favorable analyst view has sharpened investor focus on the company’s profit margin outlook. Now, we'll explore how the stronger first-quarter margins and sales performance might influence The Cheesecake...